Securities code: 002082 securities abbreviation: Wanbangde Pharmaceutical Holding Group Co.Ltd(002082) Announcement No.: 2022-002
Wanbangde Pharmaceutical Holding Group Co.Ltd(002082)
Announcement on the progress of repurchase of shares of the company
The company and all members of the board of directors guarantee that the information disclosed is true, accurate and complete without false records, misleading statements or major omissions.
Wanbangde Pharmaceutical Holding Group Co.Ltd(002082) (hereinafter referred to as “the company”) held the 8th meeting of the 8th board of directors on March 14, 2021, deliberated and adopted the proposal on share repurchase scheme of the company, and agreed to use its own funds of RMB 50 million-100 million to repurchase the company’s shares by means of centralized bidding for later equity incentive or employee stock ownership plan, The repurchase price shall not exceed RMB 17.32/share (inclusive). For details, please refer to the company’s disclosure in Securities Daily, securities times, Shanghai Securities News, China Securities News and cninfo (www.cn. Info. Com.. CN.) on March 15, 2021 Announcement on resolutions of the 8th meeting of the 8th board of directors (Announcement No.: 2021-021) and plan on repurchase of company shares (Announcement No.: 2021-023).
On March 23, 2021, the company implemented share repurchase by means of centralized bidding for the first time. For details, please refer to the disclosure in Securities Daily, securities times, Shanghai Securities News, China Securities News and cninfo (www.cn. Info. Com.. CN.) on March 24, 2021 Announcement on initial repurchase of shares of the company (Announcement No.: 2021-028).
1、 Progress of share repurchase of the company
(i) Repurchase progress as of the end of last month
As of December 31, 2021, the cumulative share repurchases of the company are as follows:
As of the date, the cumulative total transaction amount of the transaction method, the highest transaction price, the lowest transaction price, the cumulative number of repurchased shares in the company’s total shares (yuan) (yuan / share) (yuan / share), and the proportion of shares (%)
December 2021 centralized bidding 50953532.7812.649.694139july 31, 2000
2、 Other instructions
The time of the company’s first share repurchase, the number of shares repurchased and the entrusted time period of centralized bidding transaction shall comply with the relevant provisions of Articles 17, 18 and 19 of the detailed rules for the implementation of share repurchase by listed companies of Shenzhen Stock Exchange.
1. The company did not repurchase shares during the following periods:
(1) Within ten trading days before the announcement of the listed company’s regular report, performance forecast or performance express;
(2) From the date of occurrence of major events that may have a significant impact on the stock trading price of the company or in the decision-making process to two trading days after disclosure according to law;
(3) Other circumstances prescribed by the CSRC.
2. Five trading days before the date of the first share repurchase (March 23, 2021) (March 16, 2021 to March 22, 2021), the cumulative trading volume of the company’s shares was 16936154 shares. The number of shares repurchased by the company every five trading days does not exceed 25% (i.e. 4234038 shares) of the cumulative trading volume of the company’s shares in the five trading days before the date of the first share repurchase.
3. The company has not entrusted to buy back shares at the following trading hours:
(1) Opening call auction;
(2) There is no limit on the rise or fall of stock prices.
The price of shares repurchased by the company did not touch the price limited by the trading increase of the company’s shares on that day.
4. Trading within half an hour before closing
On March 24, 2021, due to the operator’s mistake in trading operation and incomplete cancellation of three entrustments that were not completed half an hour before the closing, 91100 shares were passively traded half an hour before the closing, with a transaction amount of 1136312 yuan, which did not cause abnormal fluctuations in the company’s share price. Relevant personnel have strengthened their familiarity with trading software and comprehensive study of laws and regulations related to share repurchase, Avoid the recurrence of such events. There is no entrustment to repurchase shares within half an hour before the closing of other times.
The company will continue to implement the repurchase plan according to the market situation, and will timely perform the obligation of information disclosure according to the provisions of relevant laws, regulations and normative documents during the repurchase period. Please pay attention to investment risks.
It is hereby announced.
Wanbangde Pharmaceutical Holding Group Co.Ltd(002082)
Board of directors
January 4, 2002
